This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay D is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
Ms. Sarid is a business oriented senior executive with over 30 years of operation, sales, financial and strategic experience in international hi-tech companies. In 1998 Ms. Sarid was awarded CFO of the Year in Israel by the head of economic activities in Israel. Ms. Sarid previously served as General Manager and then VP of China Activities of Syneron Medical Ltd. She has been instrumental in the successful acquisitions and mergers of a number of Medical Technology companies, and continues to serve on the Board of Directors of Alma Lasers and Cherry Imaging.